Development of a DNA damage-induced senescence model in osteoarthritic chondrocytes

Area of Science:

• Biomedical Science
• Cell Biology
• Osteoarthritis Research

Background:

• Senescent cells (SnCs) accumulate in osteoarthritis (OA) joint tissues, contributing to disease progression.
• Current senolytic therapies show promise in preclinical OA models but lack clinical efficacy in knee OA patients.
• A deeper understanding of chondrocyte senescence mechanisms is crucial for developing effective OA treatments.

Purpose of the Study:

• To establish reliable in vitro models for inducing chondrocyte senescence.
• To investigate DNA damage-related and inflammation-related senescence pathways in human OA chondrocytes.

Main Methods:

• Human OA chondrocytes were treated with etoposide to induce DNA damage-related senescence.
• Chondrocytes were exposed to chronic IL-1β to investigate inflammation-related senescence.
• Key senescence hallmarks including cell cycle arrest, DNA damage, and senescence-associated secretory profile (SASP) were evaluated.

Main Results:

• Etoposide treatment reliably induced DNA damage-related senescence in human articular chondrocytes.
• Etoposide induced loss of proliferative capacity, DNA damage accumulation, and partial SASP.
• Chronic IL-1β exposure resulted in only partial senescence marker expression, limiting conclusions about its senescence-inducing ability.

Conclusions:

• Etoposide provides a robust model for studying DNA damage-induced chondrocyte senescence.
• This etoposide-induced senescence model can aid in investigating senescence initiation in chondrocytes.
• The model offers a valuable tool for developing targeted senolytic therapies for OA.